✦ LIBER ✦

Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: A randomized clinical trial

✍ Scribed by David A. Plager; Jess T. Whitson; Peter A. Netland; Lingam Vijaya; Parthasarathy Sathyan; Devindra Sood; S.R. Krishnadas; Alan L. Robin; Robert D. Gross; Sally A. Scheib; Haydn Scott; Jaime E. Dickerson

Book ID: 116590543
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 202 KB
Volume: 13
Category: Article
ISSN: 1528-3933
DOI: 10.1016/j.jaapos.2009.04.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term clinical trial evaluating the

Short-term clinical trial evaluating the efficacy of the combination of apraclonidine 0.5% solution and betaxolol 0.25% suspension

✍ Lamberti, G. ;Pignalosa, B. ;Fusco, R. ;Pignalosa, G. ;Govanni, A. ;Sebastiani, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Comparative efficacy of gel-forming and

Comparative efficacy of gel-forming and ophthalmic solutions of 0.5% timolol in open-angle glaucoma

✍ Suresh Kumar; B. K. S. Pannu; Renu Sawhney; Rajeev Jain; Sunandan Sood 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 94 KB

Efficacy and tolerability of 0.5% timolo

Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension

✍ Thomas R. Walters; Susan Maloney; Deborah Slater; Charlie Liss; Helene Wilson; D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Short-term tolerability of once-daily ti

Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, three-period crossover pilot study

✍ Sriram Sonty; Thomas K. Mundorf; Jeanette A. Stewart; William C. Stewart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 209 KB